Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol for wheeze in young children in primary care
NL-OMON49680Phase 4Withdrawn
- Sponsor
- University Medical Center Utrecht
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Airways Infection comparing Salbutamol with Placebo (2 arms). Primary endpoint: Mean parent-reported respiratory symptom score over 5 days. Planned start May 2020; status: withdrawn.
02
Drugs
salbutamol
03
Conditions
Airways Infection
Beyond the preview
Go deeper on NL-OMON49680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49680.